Development of a method for intraparenchymal infusions of 192 IgG-saporin: a comment on Pizzo et al. (1999)
Sarter
M
M
Bruno
J P
JP
Miner
L A
LA
McGaughy
J
J
D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000633:toxicity; D018678:Cholinergic Agents / Q000008:administration & dosage / Q000633:toxicity; D000922:Immunotoxins / Q000008:administration & dosage* / Q000633:toxicity; D007263:Infusions, Parenteral / Q000379:methods; D009699:N-Glycosyl Hydrolases; D009474:Neurons / Q000187:drug effects; D016548:Prosencephalon / Q000187:drug effects / Q000473:pathology*; D051381:Rats; D054789:Ribosome Inactivating Proteins, Type 1; D000076985:Saporins
C085696:192 IgG-saporin; D000911:Antibodies, Monoclonal; D018678:Cholinergic Agents; D000922:Immunotoxins; D054789:Ribosome Inactivating Proteins, Type 1; D009699:N-Glycosyl Hydrolases; D000076985:Saporins